The advanced lung cancer inflammation index (ALI) acts as an integrated marker for assessing a patient's nutritional status and systemic inflammation, calculated using the body mass index (BMI), serum albumin (Alb) concentrations, and the NLR. Here, ALB is linked to lung carcinoma.